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Abstract 
The effects of synthetic rat adrenomedullin (rAM), a novel vasorelaxant peptide originally isolated from human pheochromocytoma. on receptor 
binding and CAMP generation were studied in cultured rat vascular smooth muscle cells (VSMC). A binding study using [“51]rAM revealed the 
presence of a single class of high-affinity (& 1.3 x lo-* M) binding sites for rAM m VSMC. The apparent K, of rat calcitonin gene-related peptide 
(rCGRP) was 3 x lo-’ M. Affinity labeling of VSMC membranes with [“‘I]rAM revealed two distinct labeled bands with apparent molecular weights 
of 120 and 70 kDa, both of which were abolished by excess unlabeled rAM or rCGRP. rAM stimulated CAMP formation with an approximate EC,, 
of lo-* M, the effect of which was additive with isoproterenol, but not with rCGRP. The rAM-induced CAMP response was unaffected by propranalol. 
indomethacin, or quinacrine, but inhibited by a CGRP receptor antagonist, human CGRP[8-371. These data suggest hat VSMC possesses pecific 
AM receptors functionally coupled to adenylate cyclase with which CGRP interacts. 
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1. Introduction 
A novel vasorelaxant peptide, termed adrenomedullin 
(AM), has recently been isolated from the acid extract of 
human pheochromocytoma [l]. Human AM with 52 
amino-acid residues hows structural homology with cal- 
citonin gene-related peptide (CGRP) and amylin in 
terms of the ring structure by disulfide bridge and C- 
terminal amide. Human AM stimulates CAMP genera- 
tion in rat platelets in vitro [l]. Intravenous bolus injec- 
tion of AM, like CGRP, caused a potent and long-lasting 
hypotensive ffect in anesthetized rats in vivo [l]. It has 
been shown that AM-like immunoreactivity (LI) [l] and 
AM mRNA [2] are present not only in normal human 
adrenal medulla, but also in lung and kidney. Further- 
more, AM-L1 circulates in human plasma [ 11, suggesting 
its role as a vasodilatory hormone. 
However, no information is yet available about the 
mechanism of vasodilatory action by AM. To elucidate 
whether there exists vascular AM receptor and its trans- 
membrane signal, the present study was designed to ex- 
amine the effects of synthetic AM on receptor binding 
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and CAMP generation in cultured rat vascular smooth 
muscle cells (VSMC). 
2. Materials and methods 
2. I. Materads 
Synthetic rat (r) and human (h) AM were synthesized by the solid 
phase method and purified by reverse-phase HPLC. rCGRP, rat amylin 
and hCGRP[8-371 were purchased from Peptide Institute Inc. (Osaka, 
Japan), isoproterenol, propranolol, quinacrine, 3-isobutyl-l-meth- 
ylxanthine (IBMX), phenylmethylsulphonyl fluoride (PMSF) and 
disuccmimidyl suberate (DSS) from Sigma Chemical (St. Louis, MO), 
and indomethacin from Wako Chemical (Osaka, Japan). Iodination of 
synthetic rAM was performed by chloramine-T method and purified 
by reverse-phase HPLC: monoiodinated [“‘I]rAM (specific activity: 
- 150 Ci/mmol) was used in the experiments. 
2.2. Cell culture 
VSMCs from the thoracic aorta of 15week-old male Wistar rats 
prepared by the explant method were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 10% fetal calf serum at 37°C in 
a humidified atmosphere of 95% air-S%CO, as described [3]. Subcul- 
tured VSMCs (l&l 5th passages) were used in the experiments. 
2.3 Bmding study 
Confluent cells (- 1 Ob cells/well) were usually incubated with 160 pM 
I”‘IlrAM at 4°C in Hanks’ balanced salt solution (HBSS) containing 
b. 1% bovine serum albumm in the same manner as ‘reported [4]. After 
completion, cells were extensively washed, solubilized in 0.5 N NaOH, 
and the cell-bound radioactivity was determined. Specific binding was 
obtained by subtracting nonspecific bmding in the presence of an excess 
(5 x 10m6 M) unlabeled rAM from total binding. 
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2.4. Determination of intracellular CAMP 
Confluent cells were incubated at 37°C for 10 min in HBSS contain- 
ing 0.5 mM IBMX. Incubation was terminated by the addition of HCl 
and intracellular CAMP was measured by a radioimmunoassay kit 
(New England Nuclear, Boston, MA) as described [4]. 
2.5. AfJinity labeling of [“‘I]rAM with VSMC membranes 
The membrane suspension from VSMCs was prepared and affinity 
labeling of [?]rAM was performed essentially in the same manner as 
described previously [S]. Briefly, cells were homogenized in 20 mM 
phosphate buffer (130 mM NaCl, 10 mM EDTA, 0.2 mM PMSF, 
10 j&ml pepstatin, 10 pg/ml leupeptin), pH 7.5, and the homogenate 
was washed, centrifuged, and resuspended in the same buffer. The 
membrane suspension (10 pg protein) was incubated with 2 nM 
[‘?]rAM at 4°C for 1 h in th e a b sence and presence of excess (5 x 10m6 
M) unlabeled rAM or rCGRP; DSS was added to a final concentration 
of 0.5 mM and incubated at 25°C for 20 min. After completion, the 
reaction mixtures were subjected to SDS-PAGE in the presence of 5% 
2-mercaptoethanol. After electrophoresis, the gels were dried and ex- 
posed to film at -70°C for 5 days. 
3. Results 
Binding of [‘251]rAM at 4°C to cultured rat VSMC was 
a time-dependent process (Fig. 1). An apparent equilib- 
rium binding was reached after l-2 h; the specific bind- 
ing was about 60% of the total binding. Binding at 37°C 
was about one-tenth that at 4°C after 1 h, and the spe- 
cific binding was only 10% of the total binding (data not 
shown). Therefore, the subsequent binding study was 
performed at 4°C for 2 h. 
Competitive binding of [12’I]rAM to rat VSMC by 
unlabeled rAM and rCGRP is shown in Fig. 2A. Unla- 
beled rAM competitively inhibited the binding of 
[lz51]rAM; Scatchard analysis of the binding data (Fig. 
TIME (min> 
Fig. 1. Specific binding of [lZ51]rAM to cultured rat VSMC as a function 
of time. Confluent cells were incubated with [‘2SI]rAM at 4°C for the 
time as indicated. Specific binding was obtained by subtracting nonspe- 
cific binding in the presence of 5 x 10e6 M unlabeled rAM from total 
binding. Each point is the mean of triplicate dishes; bars show S.E.M. 
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Fig. 2. Competitive binding of [12’I]rAM to cultured rat VSMC by 
unlabeled rAM and rCGRP. (A) Confluent cells were incubated with 
[“‘I]rAM at 4°C for 2 h in the absence and presence of unlabeled rAM 
(0) and rCGRP (m) in indicated concentrations. Each point is the mean 
of triplicate dishes. (B) Scatchard plot of rAM binding. The ratio of 
bound to free rAM is plotted against he concentrations of bound rAM. 
2B) revealed the presence of a single class of binding sites 
for rAM with the apparent dissociation constant (KJ of 
1.3 x lo-* M and the maximal binding capacity (B,,,) of 
19,000 sites/cell. rCGRP showed a less steep inhibition 
curve than rAM with the apparent inhibition constant 
(K,) of 3 x lo-’ M. Affinity labeling of VSMC mem- 
branes with [“‘I]rAM revealed two major labeled bands 
with apparent molecular weights (M,) of 120 and 70 
kDa; both bands disappeared in the presence of excess 
unlabeled rAM or rCGRP (Fig. 3). 
The effects of rAM, hAM, rCGRP and rat amylin on 
CAMP formation in cultured rat VSMC are shown in 
Fig. 4. rAM and hAM dose-dependently (10-9-10-6 M) 
stimulated CAMP formation, the approximate concen- 
trations of which for half-maximal stimulation (EC,,) 
were 6 x 10m9 M and lo-* M, respectively, whereas 
rCGRP was less potent than AM with the apparent ECsO 
of 3 x lo-’ M; rat amylin had no effect. The effect of 
CGRP receptor antagonist (hCGRP[8-371) on CAMP 
generation stimulated by rAM and rCGRP is shown in 
Fig. 5. hCGRP[8-371 dose-dependently ( 10-8-10-5 M) 
inhibited CAMP generation stimulated by rCGRP (10m6 
M) and by rAM (lo-’ M), the approximate concentra- 
tions of which for half-maximal inhibition (IC,,) were 
3 x lo-’ M and 2 x 10m6 M, respectively. 
The effects of various compounds on rAM-induced 
CAMP formation in cultured rat VSMC were tested 
(Table 1). The stimulatory effect by rAM (10m6 M) was 
additive with isoproterenol (10m6 M), but not with 
rCGRP (10m6 M). The rAMP-induced CAMP response 
was not affected by propranolol(1 Om6 M), indomethacin 
(1O-5 M), or quinacrine (10m5 M). 
4. Discussion 
AM, a novel 52-amino-acid residue peptide originally 
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Fig. 3. Autoradiograph after SDS-PAGE of affinity labeling of 
[“‘I]rAM to rat VSMC membranes. VSMC membrane suspensions 
were incubated with [‘2SI]rAM at 4°C for 1 h in the absence and 
presence of 5 x 10m6 M rAM or rCGRP, cross-linked by DSS, and 
subjected to SDS-PAGE. Molecular size markers are denoted on the 
left; arrows indicate positions of the 120- and 70-kDa labeled bands. 
isolated from human pheochromocytoma, is one of the 
most potent vasodilator in vivo [ 11. hAM relaxes precon- 
tracted rat mesenteric vascular bed in vitro, whose effect 
is not mediated by adrenergic or cholinergic receptors 
[6], suggesting the presence of distinct AM receptors in 
rat VSMC. The present study demonstrates for the first 
time the presence of specific binding sites for rAM in 
cultured rat VSMC. 
The equilibrium binding of [‘251]rAM to VSMC was 
obtained at 4°C whereas specific binding at 37°C was 
smaller than that at 4°C. The greater nonspecific binding 
of [‘251]rAM at 37°C is most likely due to degradation 
and/or internalization of [12’I]rAM during incubation as 
is the case of [“‘I]rCGRP binding to rat VSMC [4]. The 
present competitive binding of [“‘I]rAM to VSMC 
under the equilibrium condition revealed the presence of 
a single class of high-affinity binding sites for rAM. The 
apparent Kd value (1.3 x lo-’ M) estimated from 
Scatchard analysis is comparable to that of PD2 (8.32) 
to induce vasodilation in the perfused rat mesenteric 
vascular bed [6]. 
hAM [l] as well as rAM [7] stimulates CAMP forma- 
tion in rat platelets. The present study clearly shows that 
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rAM dose-dependently increased intracellular CAMP 
concentrations in cultured rat VSMC. The approximate 
ECsO by rAM (6 x 10m9 M) to induce a CAMP response 
appears to be almost comparable to the apparent K,, 
value from the binding study. Furthermore, the stimula- 
tory effect on CAMP formation by rAM was additive 
with isoproterenol, whereas j?-adrenergic antagonist 
(propranolol), cyclooxygenase inhibitor (indomethacin) 
and phospholipase A2 inhibitor (quinacrine) failed to 
inhibit the stimulatory effect by rAM. Therefore, it is 
suggested that rAM-induced CAMP formation in VSMC 
is not due to a prostanoid-dependent mechanism, but 
directly mediated by specific AM receptors functionally 
coupled to adenylate cyclase, distinct from B-adrenergic 
receptors. Since CAMP is an intracellular mediator of 
vasorelaxation, it seems most likely that the vasorelaxant 
effect by AM is exerted by CAMP in VSMC. Since there 
exists apparent structural homology between AM, 
CGRP and amylin which share the ring structure formed 
by an intramolecular disulfide linkage and the C-termi- 
nal amide [l], it is of great interest o compare the CAMP- 
generating activities by these three peptides. The rank 
order of potency to induce CAMP formation in rat 
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Fig. 4. Effects of AM-related peptides on intracellular CAMP formation 
in cultured rat VSMC. Confluent cells were incubated at 37°C for 10 
min with or without various concentrations of rAM (o), hAM (0). 
rCGRP (B) and rat amylin (A). Each point is the mean of four samples; 
bars show S.E.M. 
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VSMC in the present study is rAM I hAM > rCGRP 
>> rat amylin, whereas that in the rat platelet is 
hCGRP 2 rAM 2 hAM >> human amylin [1,7]. Such 
discrepancy may be due to the different tissue expression 
of receptor subtype and/or species difference of ligands. 
Table 1 
Effects of various compounds on rAM-induced CAMP formation in 
cultured rat VSMC 
Drugs (concentration) CAMP Formed 
(pmol/lO min/106 cells) 
The present study further demonstrates that rCGRP 
has lower binding affinity than rAM, and that rCGRP- 
induced CAMP formation was non-additive with rAM. 
The present study also showed that a CGRP receptor 
antagonist (hCGRP[8-371) dose-dependently inhibited 
rCGRP- and rAM-induced CAMP formation in VSMC. 
These data are in agreement with a recent study in which 
hAM-induced vasodilator response in the rat mesenteric 
vascular bed was markedly inhibited by hCGRP[8-371 
[6]. Taken together with the presence of specific CGRP 
receptors functionally coupled to adenylate cyclase in 
VSMC [4], it is possible to speculate that AM and CGRP 
may interact with the same receptors coupled to adenyl- 
ate cyclase in VSMC. 
None 5.1 f 1.0 
rAM (1O-6 M) 64.6 f 1.6* 
rCGRP (1O-6 M) 36.4 f 1.7* 
rCGRP (10m6 M) + rAM (10e6 M) 67.0 f 4.1*,** 
Isoproterenol ( 10m6 M) 126.0 f 6.0* 
Isoproterenol (10e6 M) + rAM (10m6 M) 156.0 zb 3.1*,** 
Propranolol (1O-6 M) 5.3 f 1.4 
Propranolol (10m6 M) + rAM (10m6 M) 66 6 f 2.1*,** 
Indomethacin (lo-’ M) 512 f 0.9 
Indomethacin (lo-’ M) + rAM (10e6 M) 62.4 + 3.2*,** 
Quinacrine (lo-’ M) 4.9 + 0.8 
Quinacrine (10e5 M) + rAM (10m6 M) 59.5 f 5.3*,** 
The affinity labeling experiment o visualize receptor 
molecules on SDS-PAGE after covalent binding of rAM 
to VSMC membranes revealed two major labeled pro- 
teins with apparent A4, of 120 and 70 kDa, both of which 
Confluent cells were incubated at 37°C for 10 min with various com- 
pounds in the absence and presence of rAM. Each value is the 
mean + S.E.M. (n = 4). *P < 0.05 vs. none. **P < 0.05 vs. rAM-non- 
treated group. 
were equally abolished by unlabeled rAM and rCGRP. 
These data are consistent with those of cardiac CGRP 
receptors in which [1251]rCGRP specifically labeled 120 
and 70 kDa proteins in porcine cardiac muscles [8]. It has 
been suggested that there may exist multiple CGRP re- 
ceptor subtypes, as based on pharmacological and bind- 
ing studies [9,10]. It should be noted that the 70 kDa 
CGRP receptor is consistently present in various tissues 
as shown by affinity labeling studies [lo]. In fact, we have 
already reported the existence of the 6&70 kDa CGRP 
receptor in cultured rat VSMC [4]. The 120 kDa protein 
observed in the present study and other study [8] may 
represent a precursor or intermediate form of the 70 kDa 
receptor and/or a 70 kDa receptor cross-linked to other 
proteins. 
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Fig. 5. Effects of CGRP receptor antagonist on CAMP formation stim- 
ulated by rAM and rCGRP in cultured rat VSMC. Confluent cells were 
incubated without (0) or with lo-’ M rAM (0) and 10m6 M rCGRP @) 
in the absence and presence of hCGRP[8-371 in concentrations as 
indicated. Each point is the mean of four samples; bars show S.E.M. 
*P -c 0.05 vs. control. 
From the present study, it is evident that AM exerts 
its vasorelaxant effect through its specific receptors in 
VSMC with which CGRP interacts, and that CAMP 
plays their intracellular mediator role. The physiological 
and pathophysiological role of AM in the regulation of 
the cardiovascular system remains to be determined. 
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